Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Viewpoint May 2004 Terrorism "Preparedness": Diversion of Resources and Erosion of Trust Victor W. Sidel, MD and Barry S. Levy, MD, MPH Virtual Mentor. 2004;6(5):242-244. doi: 10.1001/virtualmentor.2004.6.5.oped1-0405. In the Literature Jan 2002 Parity in Mental Health Coverage: Moral Hazard, Adverse Selection, and the Domenici/Wellstone Act Sam Huber Virtual Mentor. 2002;4(1):12-14. doi: 10.1001/virtualmentor.2002.4.1.jdsc1-0201.
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Viewpoint May 2004 Terrorism "Preparedness": Diversion of Resources and Erosion of Trust Victor W. Sidel, MD and Barry S. Levy, MD, MPH Virtual Mentor. 2004;6(5):242-244. doi: 10.1001/virtualmentor.2004.6.5.oped1-0405.
In the Literature Jan 2002 Parity in Mental Health Coverage: Moral Hazard, Adverse Selection, and the Domenici/Wellstone Act Sam Huber Virtual Mentor. 2002;4(1):12-14. doi: 10.1001/virtualmentor.2002.4.1.jdsc1-0201.